AzTrials
AzTrials

Cesarean Wound DisruptionNCT04587960

Delayed Primary Closure of Skin in Emergency Caesarean Section

A study testing Delayed primary closure of skin incision in Caesarean section in experimental group and Primary closure of skin incision in Caesarean section in active comparator group in people with Cesarean Wound Disruption and Cesarean Section; Infection, run by Dr.Jhuma Biswas at 1 site in India.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pregnant mothers requiring emergency cs with history of ruptured membranes would be allocated randomly into two groups in an aim to study the comparative outcome of different methods of skin closure namely primary and delayed primary closure on the incidence of wound infections requiring secondary closures and to… Read more about this study

Who is it for?
Ages 21 to 40 years, women only
What is being tested?
Delayed primary closure of skin incision in Caesarean section in experimental group and Primary closure of skin incision in Caesarean section in active comparator group
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteIndia
Study dates
1 Mar 2021to 15 Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Parturients admitted with rupture of membranes undergoing emergency CS

Who cannot join

  • Presence of intact membranes
  • Incision other than Pfannenstiel
  • Presence of pre-existing infection at the site of skin incision
  • Presence of obvious chorioamnionitis
  • Presence of any immunosuppressive condition including HIV, intake of immunosuppressive medication, h/o chemotherapy, haematological malignancies, etc.
  • Presence of other conditions interfering with wound healing like Tuberculosis, Diabetes, collagen disorders, etc.

Trial locations and contacts

1 site in 1 country.

India1 site
  • Calcutta National Medical College and Hospital

    Kolkata, West Bengal, 700047

Other trials in India

About this study

Official title: Comparative Study of Outcome Between Primary Closure and Delayed Primary Closure of Skin Incision in Emergency Caesarean Section

Pregnant mothers requiring emergency cs with history of ruptured membranes would be allocated randomly into two groups in an aim to study the comparative outcome of different methods of skin closure namely primary and delayed primary closure on the incidence of wound infections requiring secondary closures and to detect the associated risk factors increasing chance of surgical site infections.

Read the detailed description

OBJECTIVE

  • To compare the effect of two different methods of skin wound closure namely Primary Closure and Delayed Primary Closure on the incidence of wound infection and requirement for secondary skin wound repair after emergency caesarean section in patients with ruptured membranes.

RESEARCH HYPOTHESIS Caesarean Sections (CS) in emergency situation where amniotic membrane is ruptured are clean contaminated procedures which are associated with 10-20% wound disruptions. Delayed Primary Closure for managing contaminated wounds is a concept well recognized by military surgeons, which reduces wound infections. Investigators wish to conduct this prospective study to determine the efficacy of using this technique of wound closure in Caesarean Sections in patients with history of ruptured amniotic membranes. Investigators wish to study and compare the effect of this technique versus conventional primary skin closure on wound infection and incidence of secondary wound suturing in CS with ruptured membranes.

MATERIALS AND METHODS:

  1. STUDY DESIGN: Randomized controlled Trial
  2. STUDY SETTING: Tertiary teaching hospital-based trial involving obstetric patients undergoing Caesarean delivery.
  3. PLACE OF STUDY: Department of Obstetrics and Gynecology, Calcutta National Medical College and Hospital, Kolkata.
  4. PERIOD OF STUDY: From 1st March 2020 to 15th June 2021.
  5. SAMPLE SIZE: As no similar study was found in literature related to obstetric population, we have chosen an arbitrary sample size of 30 in case group and 30 in control group in this Pilot study.
  6. STUDY POPULATION:

INCLUSION CRITERIA :

  • Parturients admitted with rupture of membranes undergoing emergency CS

EXCLUSION CRITERIA :

  • Presence of intact membranes
  • Incision other than Pfannenstiel
  • Presence of pre-existing infection at the site of skin incision
  • Presence of obvious chorioamnionitis
  • Presence of any immunosuppressive condition including HIV, intake of immunosuppressive medication, h/o chemotherapy, haematological malignancies, etc.
  • Presence of other conditions interfering with wound healing like Tuberculosis, Diabetes, collagen disorders, etc.
  1. PROCEDURE:

Mothers undergoing emergency CS for various indications after rupture of membranes will be randomly allocated to two groups Study group to undergo Delayed Primary Closure of skin incision and Control group to undergo Primary closure of skin incision, after appropriate consenting.

During CS Pfannenstiel incision will be made in the skin. All patients will receive prophylactic antibiotic within thirty minutes of making abdominal incision. Depending upon the duration of membrane rupture wound will be defined either contaminated (duration of membrane rupture ≥ 12 hours) or clean contaminated (duration of membrane rupture ≤12 hours).

At the end of the procedure after closure of rectus sheath in the Study group, interrupted stitches will be taken through skin and subcutaneous tissue with 1-0 monofilament suture but knots will not be tightened and skin will be left open. Following operation, from next day onwards dressing of the wound will be done for 3 days. On 4th day, the monofilament stitches will be tightened under local anaesthesia to appose the skin. Thereafter, sutures will be removed on 7th day after operation.

In the Control group wound margins will be apposed by primary closure by interrupted stitches using 1-0 monofilament and stitches will be removed on 6th day after operation.

If there is abnormal discharge from wound, wound swabs will be taken for bacterial culture sensitivity test.

If there is wound dehiscence, timing of secondary closure will be decided based on wound health and presence of adequate granulation tissue after a period of regular wound dressing.

STASTICAL ANALYSIS PLAN Statistical methods- Linear data will be represented a mean ± standard deviation for normally distributed data and as mean (interquartile range (IQR)) for not-normally distributed data. Categorical data will represented as percentage (frequency). Comparison of means will be done with Mann Whitney U test and comparison of proportions with Chi - squared test or Fisher's exact test as appropriate. Multivariate modeling with logistic regression will be used to compare different variables between the primary closure and delayed primary closure groups.

Being tested
Delayed primary closure of skin incision in Caesarean section in experimental group, Primary closure of skin incision in Caesarean section in active comparator group
Medical subject headings
Infections

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Delayed primary closure of skin incision in Caesarean section in experimental groupProcedure or surgery

    Delayed closure of skin wound of emergency Caesarean section following wound dressing for 2-3 days in experimental group

  • Primary closure of skin incision in Caesarean section in active comparator groupProcedure or surgery

    Primary closure of skin wound (incisional) at the time of emergency Caesarean section in active comparator group

Study groups in NCT04587960
Study groupRoleWhat they receive
Primary closure of Cesarean woundActive comparatorImmediate closure of skin incision where healing occurs by primary intention
Receives: Procedure: Primary closure of skin incision in Caesarean section in active comparator group
Delayed primary closure of Cesarean woundExperimentalDelayed closure of skin incision following regular wound dressing for 2 to 3 days.
Receives: Procedure: Delayed primary closure of skin incision in Caesarean section in experimental group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Surgical site infections requiring secondary closure

    Incidence of surgical site infections requiring secondary closure

    Measured: 6 days from the day of surgery

Secondary outcomes (1)
  1. Prolonged hospital stay

    Requiring prolonged hospital stay due to wound infection

    Measured: more than 7 days after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Oct 2020
  2. Study start1 Mar 2021
  3. Primary completion15 Jun 2021
  4. Study completion15 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patients were randomized to delayed primary closure (group A, n=40) or primary closure (group B, n=30)
Masking
None (open label)
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04587960
Sponsor's protocol ID
ECR/771/Inst/WB/2015/RR-18
Status last verified
Sep 2021
First submitted
8 Oct 2020
Last updated
1 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPD would be used for this study only

Questions about this trial

What is this clinical trial studying?

A study testing Delayed primary closure of skin incision in Caesarean section in experimental group and Primary closure of skin incision in Caesarean section in active comparator group in people with Cesarean Wound Disruption and Cesarean Section; Infection, run by Dr.Jhuma Biswas at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Surgical site infections requiring secondary closure (time frame: 6 days from the day of surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in